Researchers revealed that the modulation of HTRA3 in tumorigenesis might be dual, either inhibitory or promoting, depending on the specific tissues, stages of cancer progression etc. On one hand, HTRA3 expression is low in endometrial cancer, ovarian cancer, and lung cancer (23, 26). This evidence concerns the gene HTRA3 and endometrial cancer.